Precision BioSciences (NASDAQ: DTIL) reported Q4 EPS of ($0.26), $0.06 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $10.59 million versus the consensus estimate of $6.81 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.